Company intelligence / Profile preview

TicTwo Therapeutics Inc.

Wilmington, Delaware, USAventureradar.com ↗

Ownership: Private
Development stage: Preclinical

Overview

TicTwo Therapeutics Inc. is a newly established biotechnology/pharmaceutical company incorporated in Delaware on February 29, 2024. It was created as a subsidiary of Alembic Global Holding SA, which itself is wholly owned by Alembic Pharmaceuticals Limited. The company has not yet publicly disclosed any products, pipeline programs, or clinical results[1][5].

Therapeutic areas: Other
Modalities: Not specified in available sources (likely early-stage, modalities not yet disclosed)
Industry: Biotech

Drug pipeline

1 asset

TicTwo allosteric TYK2 inhibitor

Preclinical

Beyond the preview

Go deeper on TicTwo Therapeutics Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TicTwo Therapeutics Inc..

Explore the full profile